摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-5-[5-(2,4-dimethoxy-pyrimidin-5-yl)-furan-2-ylmethylene]-3,5-dihydro-imidazol-4-one | 1263777-64-5

中文名称
——
中文别名
——
英文名称
2-amino-5-[5-(2,4-dimethoxy-pyrimidin-5-yl)-furan-2-ylmethylene]-3,5-dihydro-imidazol-4-one
英文别名
(4E)-2-amino-4-[[5-(2,4-dimethoxypyrimidin-5-yl)furan-2-yl]methylidene]-1H-imidazol-5-one
2-amino-5-[5-(2,4-dimethoxy-pyrimidin-5-yl)-furan-2-ylmethylene]-3,5-dihydro-imidazol-4-one化学式
CAS
1263777-64-5
化学式
C14H13N5O4
mdl
——
分子量
315.288
InChiKey
CEEBJLCKQZCYCQ-WEVVVXLNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    125
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
    申请人:NOSCIRA, S.A.
    公开号:EP2281824A1
    公开(公告)日:2011-02-09
    The present invention is related to a family of furan-imidazolone derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same.
    本发明涉及一类含有呋喃-咪唑啉酮衍生物的公式(I)化合物家族,以及它们在治疗认知、神经退行性或神经性疾病或障碍,如阿尔茨海默病或帕森病中的应用。本发明还涉及包含相同化合物的药物组合物。
  • [EN] FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS<br/>[FR] DÉRIVÉS DE FURANE-IMIDAZOLONE POUR LE TRAITEMENT DE MALADIES OU TROUBLES COGNITIFS, NEURODÉGÉNÉRATIFS OU NEURONAUX
    申请人:NOSCIRA SA
    公开号:WO2011015646A2
    公开(公告)日:2011-02-10
    The present invention is related to a family of furan-imidazolone derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same.
查看更多